Funding round
Oura Series C
Oura, which works in wearable health device manufacturing in Oulu, raised $100M in a Series C round announced on 4 May 2021, led by The Chernin Group and Elysian Park. 14 firms took part. It is Oura's fifth venture round on record; the one before was a Series B in Mar 2020.
$100M
Amount raised
Not disclosed
Post-money valuation
14
Investors
2 leads
Valuation
What this round says about the price
Oura did not disclose a valuation in this round. It came 14 months after Oura's Series B. It is 8.2% of the $1.21B Oura has raised in the venture rounds on record. Oura raised again 43 months later: a Series D round of $200M in Dec 2024, at $5.20B post-money.
Oura's funding rounds
Oura has 7 venture rounds on record and 1 other deal. This one is highlighted.
- Seed 1 Jan 2013 $2.3M
- Seed 11 Nov 2015, led by Lifeline Ventures $2.3M
- Series A 30 Nov 2016 $5.3M
- Series B 17 Mar 2020 $28M
- Series C this round 4 May 2021, led by The Chernin Group and Elysian Park $100M
- Series D 19 Dec 2024, led by Fidelity Management & Research Company and Dexcom $200M$5.20B post-money
- Debt not a venture round 22 Sep 2025 $250M
- Series E 22 Sep 2025 $875M$11.00B post-money
Investors
Who put money in
The Chernin Group and Elysian Park led the round with 12 other firms.
Lead investors
- backs 50 venture-backed companies new investor
- Elysian Park new investor
Also in the round
- Temasek backs 195 venture-backed companies new investor
- backs 32 venture-backed companies new investor
- backs 7 venture-backed companies new investor
- Bedford Ridge new investor
- One Capital new investor
- backs 99 venture-backed companies new investor
- Square new investor
- MSD Capital new investor
- backs 47 venture-backed companies new investor
- backs 48 venture-backed companies new investor
- backs 8 venture-backed companies new investor
- Marc Benioff
Use of proceeds
What the money is for
According to the announcement, the money goes to hiring, product development, sales and marketing, scaling operations and working capital.
- Hiring
- Product development
- Sales and marketing
- Scaling operations
- Working capital
Comparable rounds
How it compares
51 Series C rounds in Medical Supply Manufacturers within a year either side disclosed an amount; the median was $40M, and this round was 2.5 times the median. The closest in time, other companies' Series C rounds in Medical Supply Manufacturers:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Medical Supply Manufacturers | 13 May 2021 | $7.0M | not disclosed | Seneca Partners |
| Medical Supply Manufacturers | 13 Apr 2021 | $115M | not disclosed | Credit Suisse Entrepreneur Capital Ltd and Endeavour Vision |
| Medical Supply Manufacturers | 3 Jun 2021 | $4.0M | not disclosed | WNY Impact Investment Fund and Murray Capital |
| Medical Supply Manufacturers | 29 Jul 2021 | $220M | not disclosed | RA Capital |
| Neuralink Medical Supply Manufacturers | 29 Jul 2021 | $205M | not disclosed | Vy Capital |
| Medical Supply Manufacturers | 20 Jul 2021 | $105M | not disclosed | Transformation Capital |
| Medical Supply Manufacturers | 27 Jul 2021 | $80M | not disclosed | BGF |
| Medical Supply Manufacturers | 4 Mar 2021 | $65M | not disclosed | Ambix Life Science Fund I, L.P. |
Sources
Where this comes from
Reported by 4 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Oura raise in its Series C round?
Oura raised $100M in its Series C round, announced in May 2021.
Who led Oura's Series C round?
The Chernin Group and Elysian Park led it, with Temasek, JAZZ Venture Partners, Eisai Innovation, Bedford Ridge and One Capital and 7 more.
What was Oura's valuation at the Series C round?
It was not disclosed.
How does it compare with other Series C rounds in Medical Supply Manufacturers?
51 Series C rounds in Medical Supply Manufacturers within a year either side disclosed an amount; the median was $40M, and this round was 2.5 times the median.
Did Oura raise again after this round?
Yes: a Series D round in Dec 2024 of $200M at $5.20B post-money.